Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells. Mittal, D.; Caramia, F.; Michiels, S.; Joensuu, H.; Kellokumpu-Lehtinen, P. L.; Sotiriou, C.; Loi, S.; Smyth, M. J.. Cancer Res. 2016; 264-74: p.264-74. doi:10.1158/0008-5472.CAN-15-1567 10.1158/0008-5472.CAN-15-1567. Epub 2016 Jan 7.Article
Oncostat